Boryung to register 2 process patents for Tamsulosin and other.

Published: 2005-08-17 06:59:00

Updated: 2005-08-17 06:59:00

Boryung announced on Aug. 10 that two patents were registered in Korea including a purification process for Tamsulosin, a drug for prostate enlargement, characterized in which a tamsulosin carboxylate salt with 99.0% of high quality be prepared by using carboxylic acid and then converting it to t...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK